Gilead Sciences files quarterly report (10-Q) for the period ended Sep 30, 2025

Gilead Sciences filed its quarterly report on Form 10-Q with the SEC on Nov 7, 2025, 4:08 PM ET, covering the quarter ended Sep 30, 2025. It reports fiscal Q3 2025 results.

• Revenue: $7.77B (+3.0% from $7.54B a year earlier)
• Operating income: $3.33B (+274.7% from $888.0M a year earlier)
• Net income: $3.05B (+143.6% from $1.25B a year earlier)
• Diluted EPS: $2.43 (+143.0% from $1.00 a year earlier)
• Form 10-Q accepted by EDGAR Nov 7, 2025, 4:08 PM ET
• Accession number 0000882095-25-000047

SEC filing 10-Q · accession 0000882095-25-000047 · sec.gov ↗